Study of the Clinical Impact of Drugs Interactions of Acenocoumarol

Authors

  • Safia lazreg EPH de Rélizane, N°3, city 160 ilots, Oules Adda Essenia, Oran 31005, Algéria
  • Habiba Fetati EHU d’Oran, service de pharmacovigilance

Keywords:

Acenocoumarol, drug interactions, criticality index

Abstract

One of the problems linked to the use of acenocoumarol in therapy is the intra and interindividual variability of the doses necessary to obtain the desired INR; this may be due to several factors, including drug interactions. This is how we felt the need and the importance of undertaking this work which aims to identify the drugs most likely to interact with acenocoumarol and to assess the risk level of these interactions. This is a prospective, single-center cross-sectional study from January 01, 2017 until April 30, 2017, conducted at the pharmacovigilance service of the Oran EHU. In order to assess the risk level of an interaction, we used an interaction weighting method which allowed us to calculate the criticality indices (CI). The results highlighted 22 drugs at high risk of interacting with acenocoumarol of which amiodarone, omeprazole and diclofenac sodium are the most involved. This work was carried out with the aim of optimizing and securing acenocoumarol treatment.

References

. VIDAL expert 2016.

. Revue Prescrire 2014. Tome 33 N° 362

. ANSM - 2016 September. Thesaurus of drug interactions. www.ansm.sante.fr

. Karen Baxter. Slockley's Drugs Interactions 2014 (Ninth edition)

. Gschwind L. et al. Identification and weighting of the most critical “real-life” drug – drug interactions with acenocoumarol in a tertiary care hospital. Eur J Clin Pharmacol.2012.

. Sintrom® monograph. Vidal 2016.

. M. Teichert et al. Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment. British Journal of Haematology, 153, 379–385 DOI:10.1111/j.1365-2141.2011.08633.x

. Schelleman H, et al. Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. Clin pharmacol ther 2008.

. Matthijs L. Becker. Drug-drug interaction with metronidazole and itraconazole in patients using acenocoumarol. European journal of clinical pharmacology.76, 1457-1464 (2020).

. Lozano R., Fruto A., time course of the drug-drug interactionof acénocoumarol-miconazole. International journal of clinical pharmacology and therapeutics.2017. Letter of the editor.

. Penning-van beest F, et al. Main comedications associated with major bleeding during anticoagulant therapy with coumarins. Eur j clin pharmacol 2005;61:439-444.

Downloads

Published

2020-10-24

How to Cite

lazreg, S. ., & Fetati, H. . (2020). Study of the Clinical Impact of Drugs Interactions of Acenocoumarol. American Scientific Research Journal for Engineering, Technology, and Sciences, 73(1), 111–119. Retrieved from https://asrjetsjournal.org/index.php/American_Scientific_Journal/article/view/6127

Issue

Section

Articles